Key Details
Last Dividend
$107.81Annual ROE
-888.93%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 8, 2024Recent annual earnings:
Mar 21, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Jun 24, 2005Next split:
N/ARecent split:
Jul 28, 2023Analyst ratings
Recent major analysts updates
Screeners with BIOL included
Market Data
Price
Market cap
Technical
Dividend
Events
Dividend per share
Dividend yield
Other
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Similar stocks
LAKE FOREST, CA / ACCESSWIRE / October 1, 2024 / BIOLASE, Inc. (NASDAQ:BIOL) (the "Company"), a global leader in dental lasers, today announced that the Company and its direct domestic subsidiaries have voluntarily initiated Chapter 11 proceedings (the "Bankruptcy Petitions") in the United States Bankruptcy Court for the District of Delaware (the "Court"). BIOLASE will seek Court approval to continue operating during the proceedings and remains focused on providing its customers with its award-winning dental lasers and customer service.
LAKE FOREST, CA / ACCESSWIRE / August 8, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), a leader in dental laser technology, today reported its financial results for the second quarter ended June 30, 2024. "We experienced another strong quarter in consumable revenue, recording our second-highest mark ever and achieving over 600 recurring subscriptions," commented John Beaver, President and Chief Executive Officer of BIOLASE.
BIOLASE, Inc. (NASDAQ: BIOL) Q1 2024 Earnings Conference Call on May 13, 2024 at 4:30 PM ET. Company representatives include Michael Polyviou, John Beaver, and Jennifer Bright. Conference call participants include Bruce Jackson and Ed Woo. Operator will begin the call in a listen-only mode.
LAKE FOREST, CA / ACCESSWIRE / March 14, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally recognized leader in dental laser technology, today announced that it will release fourth quarter and full year 2023 financial and operating results on Thursday, March 21, 2024, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m.
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Biolase (NASDAQ: BIOL ) stock is taking a beating on Friday following the release of its earnings report for the first quarter of 2023. The bad news for investors in BIOL stock is the company's earnings per share of -18 cents for the period.
BIOLASE, Inc. (NASDAQ:BIOL ) Q4 2022 Earnings Conference Call March 28, 2023 4:30 PM ET Company Participants Todd Kehrli - IR John Beaver - President and CEO Jennifer Bright - CFO Conference Call Participants Bruce Jackson - The Benchmark Company Frank Takkinen - Lake Street Capital Markets Anthony Vendetti - Maxim Group Edward Woo - Ascendiant Capital Operator Greetings. Welcome to the BIOLASE 2022 Fourth Quarter and Full Year Financial Results Call.
FAQ
- What is the ticker symbol for BIOLASE?
- Does BIOLASE pay dividends?
- What sector is BIOLASE in?
- What industry is BIOLASE in?
- What country is BIOLASE based in?
- When did BIOLASE go public?
- Is BIOLASE in the S&P 500?
- Is BIOLASE in the NASDAQ 100?
- Is BIOLASE in the Dow Jones?
- When was BIOLASE's last earnings report?
- When does BIOLASE report earnings?
- Should I buy BIOLASE stock now?